Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2006-09-12
2006-09-12
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S219000, C514S647000, C514S630000
Reexamination Certificate
active
07105699
ABSTRACT:
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.
REFERENCES:
patent: 4556676 (1985-12-01), Welch, Jr. et al.
patent: 4981870 (1991-01-01), Koe
patent: 5061728 (1991-10-01), Koe
patent: 5788986 (1998-08-01), Dodman
patent: 6245782 (2001-06-01), Serebruany et al.
W.M. Welch et al., “Nontricyclic Antidepressant Agents Derived from cis-and trans-1-Amino-4-aryltetralins”, J. Med. Chem., 27, 1508-1515 (1984).
V.L. Serebruany et al., “Platelet Inhibition By Sertraline And N-Desmethylsertraline: A Possible Missing Link Between Depression, Coronary Events, And Mortality Benefits Of Selective Serotonin Reuptake Inhibitors”, Pharmacological Research, 43 (5), 453-461 (2001).
B.A. Hamelin et al., “The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin”, Clinical Pharmacology & Therapeutics, 60 (5), 512-521 (1996).
R.A. Ronfeld et al., “Pharmacokinetics of Sertraline and its N-Demethyl Metabolite in Elderly and Young Male and Female Volunteers”, Clinical Pharmacokinet, 32, 22-30 (1997).
C. Sanchez and J. Hyttel, “Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding”, Cellular and Molecular Neurobiology, 19, (4), 467-489, (1999).
B.K. Koe et al., “Sertraline, 1S,4S-N-Methyl-4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Naphthylamine, a New Uptake Inhibitor with Selectivity for Serotonin”, The Journal of Pharmacology And Experimental Therapeutics 226, (3), 686-700, (1983).
Deninno, Michael P.; Eller, C; Etienne J B: “The preparation and intra-and intermocular addition reactions of acylic n-acylimines: Application to the synthesis of (+−) sertraline” Journal of Organic Chemistry, American Chemical Society. Easton, US, vol. 66, 2001, pp. 6988-6993, XP002902612, ISSN: 0022-3263; scheme 4 p. 6992.
Fuller, Ray W. et al.: Prog. Neuro-Psychopharmacol. Bio. Psychiat., vol. 19, 1995, pp. 135-149, XP002270139 abstract.
Harrison, Ian T., Harrison Shuyen: “Compendium of Organic Synthetic Methods” 1971, John Wiley & Sons, New York, XP002270140, p. 258-259.
Currie Mark G.
Fang Qun Kevin
Jerussi Thomas P.
Davis Brian
Sepracor Inc.
LandOfFree
Treatment of CNS disorders with trans... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of CNS disorders with trans..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of CNS disorders with trans... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532929